Common Stock
- Symbol
- SSII
- Exchange
- NASDAQ
- Classification
- COMMON
Current Report · Items 8.01, 9.01 · 8-K
SSIINASDAQEQUITYCurrent
Item 8.01 Other Events. On September 10, 2026, SSi issued a press release which provided an update on the Company’s continuing progress and milestones. A copy of the press release is included as Exhibit 99.1 to this Current Report.
We are a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. We design, manufacture and market an advanced, next-generation and affordable surgical robotic system called the SSi Mantra Surgical Robotic System (the “SSi Mantra”) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic and cardiac surgeries. While surgical robotic systems have gained acceptance globally in the past two decades for providing greater efficiency, better clinical outcomes and reducing healthcare costs, access to such systems remains largely limited to developed countries such as the United States (the “U.S.”), the European Union (the “EU”) and Japan. With the SSi Mantra, we are breaking down barriers and accelerating access to surgical robotics technologies in underserved regions of the world.
SS INNOVATIONS INTERNATIONAL, INC. · 8-K · Filed 2026-09-10
EX-99.1 2 ea030502401ex99-1.htm PRESS RELEASE, DATED SEPTEMBER 10, 2026 Exhibit 99.1 SS Innovations Provides Update on Continuing Progress and Milestones -- Advancing global expansion, pediatric robotic surgery and telesurgery -- -- Growing SSi Mantra installations, procedures and utilization -- FORT LAUDERDALE, Fla. - September 10, 2026 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today provided an update on the Company’s continuing progress and milestones. Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “Our advanced, cost-effective SSi Mantra surgical robotic system (the “SSi Mantra”) is benefitting lives globally, one patient at a time, from a 45-day old baby needing kidney surgery in India to a cardiac patient in Sri Lanka. Our progress in democratizing access to state-of-the-art surgical robotic care continues to be reflected in growing SSi Mantra installations, procedures and utilization.” Recent Company Progress and Milestones:…
Open exhibit ↗